Our recent investigations on RBM39-RRM3-, SAFA-RGG- and hnRNPK-RGG- [3, 22, 23] derived cell-penetrating peptides revealed that treating cells with a penetratin-tagged peptide from these functional domains inhibited cancer cell growth and survival. The gene discussed is HNRNPK; the disease is cancer.